US buys 100 million more Moderna vaccines

Washington: The United States announced on Friday that it would purchase another 100 million more Covid-19 vaccine candidates developed by Moderna, in a report that the government had given it the opportunity to secure a greater supply of Pfizer jabs.

The agreement brings the total dose of Moderna purchased by the United States to 200 million, sufficient to vaccinate 100 million people with a two-shot regimen.

“By June 2021, we will have another 100 million doses from Moderna, which will further expand the dose supply across the Operation Warp Speed ​​portfolio of vaccines,” said Secretary of Health and Welfare Alex Azar. I will.

New orders will be delivered by the second quarter of 2021, and the first orders will be completed by the first quarter, according to a statement from a New York-based biotechnology company.

The total federal funding allocated to Moderna for the vaccine mRNA-1273, co-developed with the National Institutes of Health (NIH), currently amounts to $ 4.1 billion.

The latest deal said the U.S. decided to extend orders for Pfizer-BioNTech vaccines beyond the 100 million initial orders during the summer, allowing other countries to purchase valuable supplies. After the media reported.

After an independent expert committee voted in favor on Thursday, it is believed that an emergency permit for Pfizer Jab, which is also a double-dose regimen, is imminent.

A similar panel of experts was convened on 17 December to discuss the Moderna-NIH vaccine, and urgent approval may soon follow.

It has been shown to be 94.1% effective in clinical trials involving 30,000 people.

Both of these front runners use mRNA (messenger ribonucleic acid) technology. This is a new approach that provides human cells with genetic instructions to express the surface proteins of the SARS-CoV-2 virus.

It simulates an infection and prepares the immune system in case a real virus is encountered.

The development of these vaccines is faster than traditional approaches, which often rely on the use of weakened or inactivated forms of disease-causing microorganisms.

The main drawback that has been identified so far is the need to store mRNA molecules wrapped in fat particles at very low temperatures. It is -70 degrees Celsius for Pfizer and -20 degrees Celsius for Moderna.

US buys 100 million more Moderna vaccines

Source link US buys 100 million more Moderna vaccines

Related Articles

Back to top button